AKT1 and gastric cancer: For example, Wan et al. demonstrated that the anti-gastric cancer activity of ginsenoside CK is related to the inhibition of the PI3K/AKT/NF-κB pathway, and the anti-cancer effect of ginsenoside CK is better than that of ginsenoside Rb1 [33].